In a T-cell-inflamed mouse model of head and neck squamous cell carcinoma, local injection of a STING agonist into the tumor lesion, followed by anti-PD-L1 treatment, led to successful tumor control and complete rejection [84]. This evidence concerns the gene CD274 and neoplasm.